Skip to main content

Clinical trial BAY 88-8223 / 16996

A Phase 4 long-term follow-up study to define the safety profile of radium-223 dichloride

Cancers
Organ Multiple
Trial status Trial closed for recruitment
Investigator
Trial type
Interventional without experimental drug
Phase Trial phase 4
Academic trial Non
Sponsor Bayer
EudraCT Identifier 2014-002407-25
BECT Identifier ?
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02312960
Inclusion criteria Subject was previously enrolled in a selected company-sponsored feeder trial, and has received at least 1 dose of radium-223 dichloride or placebo in the feeder trial.
Last update